News Archive
The beetle's back and the crab's shell owe their toughness to a common compound called chitin that now appears to trigger airway inflammation and possibly asthma, UCSF scientists have found.
A new study sheds light on how treatment of the "superbug" known as MRSA with certain antibiotics can potentially make patients sicker. The findings by Cedars-Sinai scientists, published today in the journal Cell Host & Microbe, could have implications for managing the bug, a virulent form of the common staph infection that can be difficult to control.
BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company's potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI's plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.
From staying hydrated to avoiding jet lag, Cooper Aerobics is making a commitment to help Flexjet owners prevent health issues while traveling. As part of its new alliance with Cooper Aerobics – a prestigious health and wellness center in Dallas – Flexjet, one of the world's leading fractional jet ownership services providers, has selected Founder and Chairman Kenneth Cooper, M.D., M.P.H., and CEO Tyler Cooper, M.D., M.P.H., as its official health advisors.
People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.
› Verified 7 days ago